AYTU BIOPHARMA, INC - FORM 10-Q - EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - November 12, 2020

Attached files

file filename
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - AYTU BIOPHARMA, INCaytu_ex312.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - AYTU BIOPHARMA, INCaytu_ex311.htm
10-Q - FORM 10-Q - AYTU BIOPHARMA, INCaytu_10q.htm
 
Exhibit. 32.1
 
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S. C. SECTION 1350 AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 
In connection with the filing of the quarterly report on Form 10-Q for the quarter ended September 30, 2020 (the “Report”) by Aytu BioScience, Inc. (the “Company”), each of the undersigned hereby certifies that:
 
1.            
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and
 
2.            
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 

 
 
 
 
 
Date: November 10, 2020 
By:  
/s/  Joshua R. Disbrow
 
 
 
Joshua R. Disbrow
 
 
 
Chief Executive Officer (Principal Executive Officer)
 
  
 
 

 
 
 
 
 
Date: November 10, 2020 
By:  
/s/  David A. Green
 
 
 
David A. Green
 
 
 
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
 
  
 
 
 
 
 

Stock widget

Investing forum

AYTU BIOPHARMA, INC Reports